HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doubts about the efficacy of tolvaptan for polycystic kidney disease.

AuthorsClark L Anderson
JournalClinical nephrology (Clin Nephrol) Vol. 93 Issue 6 Pg. 307-309 (06 2020) ISSN: 0301-0430 [Print] Germany
PMID32000887 (Publication Type: Letter, Comment)
Chemical References
  • Antidiuretic Hormone Receptor Antagonists
  • Tolvaptan
Topics
  • Antidiuretic Hormone Receptor Antagonists
  • Humans
  • Polycystic Kidney Diseases
  • Polycystic Kidney, Autosomal Dominant
  • Tolvaptan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: